PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.02%
Revenue growth under 50% of AVGO's 1.64%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-3.26%
Negative gross profit growth while AVGO is at 0.80%. Joel Greenblatt would examine cost competitiveness or demand decline.
-3.40%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.06%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-0.75%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-0.53%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-1.07%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.09%
Maintaining or increasing dividends while AVGO cut them. John Neff might see a strong edge in shareholder returns.
38.46%
OCF growth above 1.5x AVGO's 4.82%. David Dodd would confirm a clear edge in underlying cash generation.
1040.43%
FCF growth above 1.5x AVGO's 4.95%. David Dodd would verify if the firm’s strategic investments yield superior returns.
68.63%
10Y revenue/share CAGR under 50% of AVGO's 727.62%. Michael Burry would suspect a lasting competitive disadvantage.
13.51%
5Y revenue/share CAGR under 50% of AVGO's 82.53%. Michael Burry would suspect a significant competitive gap or product weakness.
19.91%
3Y revenue/share CAGR under 50% of AVGO's 48.79%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
103.13%
10Y OCF/share CAGR under 50% of AVGO's 1968.38%. Michael Burry would worry about a persistent underperformance in cash creation.
-1.85%
Negative 5Y OCF/share CAGR while AVGO is at 118.66%. Joel Greenblatt would question the firm’s operational model or cost structure.
35.56%
3Y OCF/share CAGR at 75-90% of AVGO's 44.89%. Bill Ackman would press for improvements in margin or overhead to catch up.
227.96%
Below 50% of AVGO's 1296.76%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
16.17%
Below 50% of AVGO's 187.54%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
27.56%
Below 50% of AVGO's 368.46%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
81.65%
Below 50% of AVGO's 386.36%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
68.77%
Positive 5Y equity/share CAGR while AVGO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
101.75%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
341.28%
Below 50% of AVGO's 2095.23%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
99.61%
5Y dividend/share CAGR at 50-75% of AVGO's 162.50%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
37.84%
3Y dividend/share CAGR 1.25-1.5x AVGO's 33.84%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
1.02%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
4.80%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.26%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.34%
BV/share growth above 1.5x AVGO's 0.81%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.03%
Debt shrinking faster vs. AVGO's 0.08%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-1.26%
Our R&D shrinks while AVGO invests at 3.51%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.95%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.